Department of Radiology, Academic Medical Center Amsterdam, Amsterdam, The Netherlands.
Clin Radiol. 2011 Jan;66(1):30-7. doi: 10.1016/j.crad.2010.06.016. Epub 2010 Sep 29.
To evaluate the minimal iodine contrast medium load necessary for an optimal computed tomography colonography tagging quality.
Faecal occult blood test positive patients were randomly selected for one of three iodine bowel preparations: (1) 3 × 50 ml meglumine ioxithalamate (45 g iodine), (2) 4 × 25 ml meglumine ioxithalamate (30 g iodine); or (3) 3 × 25 ml (22.5 g iodine) meglumine ioxithalamate. Two experienced readers assessed the tagging quality per colonic segment on a five-point scale and the presence of adherent stool. Also semi-automatic homogeneity measurements were performed. Patient acceptance was assessed with questionnaires.
Of 70 eligible patients, 45 patients participated (25 males, mean age 62 years). Each preparation group contained 15 patients. The quality of tagging was insufficient (score 1-2) in 0% of segments in group 1; 4% in group 2 (p<0.01 versus group 1); and 5% in group 3 (p=0.06 versus group 1). In group 1 in 11% of the segments adherent stool was present compared with 49% in group 2 and 41% in group 3 (p<0.01, group 2 and 3 versus group 1). Homogeneity was 85, 102 (p<0.01), and 91 SD HU (p=0.26) in groups 1, 2, and 3, respectively. In group 1 two patients experienced no burden after contrast agent ingestion compared to one patient in group 2 and nine patients in group 3 (p=0.017).
A dose of 3 × 50 ml meglumine ioxithalamate is advisable for an optimal tagging quality despite beneficial effects on the patient acceptance in patients receiving a lower dose.
评估用于最佳 CT 结肠成像标记质量的最小碘对比剂负荷。
粪便潜血试验阳性的患者被随机分为三组碘肠准备之一:(1)3×50ml 葡甲胺碘海醇(45g 碘),(2)4×25ml 葡甲胺碘海醇(30g 碘);或(3)3×25ml(22.5g 碘)葡甲胺碘海醇。两名经验丰富的读者按五分制评估每个结肠段的标记质量和附着粪便的存在。还进行了半自动均匀性测量。通过问卷调查评估患者的接受程度。
70 名合格患者中有 45 名患者参加(25 名男性,平均年龄 62 岁)。每组各有 15 名患者。标记质量不足(评分 1-2)的节段在组 1中为 0%;在组 2中为 4%(p<0.01 与组 1相比);在组 3中为 5%(p=0.06 与组 1相比)。在组 1 中,11%的节段存在附着粪便,而在组 2 中为 49%,在组 3 中为 41%(p<0.01,组 2 和 3 与组 1 相比)。组 1、2 和 3 的均匀性分别为 85、102(p<0.01)和 91 SD HU(p=0.26)。在组 1 中,与组 2 中的 1 名患者和组 3 中的 9 名患者相比,有 2 名患者在摄入对比剂后没有负担(p=0.017)。
尽管在接受较低剂量的患者中对患者接受度有有益影响,但 3×50ml 葡甲胺碘海醇的剂量是最佳标记质量的建议剂量。